Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts

Veterinary Surgery

Volumn 26, Issue 3, 1997, Pages 189-194

  Aronson, Lillian R ^a   Gacad, Reynaldo C ^b   Kaminsky Russ, Kristine ^b   Gregory, Clare R ^b   Mullen, Kevin D ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BRAIN LEVEL; CHEMISTRY; CONGENITAL MALFORMATION; DOG; DOG DISEASE; FEMALE; MALE; PATHOLOGY; PORTAL VEIN; RADIOASSAY;

ABNORMALITIES; ANIMALS; BENZODIAZEPINES; BRAIN CHEMISTRY; DOG DISEASES; DOGS; FEMALE; MALE; PORTAL SYSTEM; RADIOLIGAND ASSAY; RECEPTORS, GABA-A;

EID: 0031138031     PISSN: 01613499     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-950X.1997.tb01483.x     Document Type: Article

References (28)

1. Whiting PG, Peterson SL: Portosystemic shunts, in Slatter (ed): Textbook of Small Animal Surgery (ed 2). Philadelphia, PA, Saunders, 1993, pp 660-677
2. Maddison JE: Hepatic encephalopathy. J Vet Intern Med 6:341-353, 1992
3. Maddison JE: Canine congenital portosystemic encephalopathy: A spontaneous animal model of chronic hepatic encephalopathy, in Bengtsson F, Jeppsson B, Almdal T, et al (eds): Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange. Boca Raton, FL, CRC, 1990, pp 100-104
4. Mullen KD, Szauter KM, Kaminsky K, et al: Detection and characterization of endogenous benzodiazepine activity in both animal models and humans with hepatic encephalopathy, in Butterworth RF (ed): Hepatic Encephalopathy. Clifton, NJ, Humana, 1989, pp 287-294
5. Basile AS, Gammal SH: Evidence for the involvement of the benzodiazepine receptor complex in hepatic encephalopathy. J Clin Neuropharmacol 11:401-422, 1988
6. Gammal SH, Jones AE: Hepatic encephalopathy. Med Clin North Am 73:793-801, 1989
7. Mullen KD: Benzodiazepine compounds and hepatic encephalopathy. N Engl J Med 325:509-510, 1991
8. Butterworth RF: Pathogenesis and treatment of portal-systemic encephalopathy: An update. Dig Dis Sci 37:321-327, 1992
9. Butterworth RF: Benzodiazepine receptors and hepatic encephalopathy. Hepatology 11:499-501, 1990
10. Mullen KD, Basile AS: Benzodiazepine-receptor antagonists and hepatic encephalopathy: Where do we stand? Gastroenterology 105:937-940, 1993
11. Mullen KD, Szauter KM, Kaminsky-Russ K: Endogenous benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336:81-83, 1990
12. Olasmaa M, Rothstein JD, Guidotti A, et al: Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J Neurochem 55:2015-2023, 1990
13. Manning RW, Callahan AM, Davis LG, et al: Using radioreceptor binding assays to identify endogenous ligands, in O'Brien RA (ed): Receptor Binding in Drug Research. Marcel Dekker, New York, 1986, pp 393-406
14. Hume HA, ERB WH, Stevens LW, et al: Treatment of hepatic encephalopathy by surgical exclusion of the colon. JAMA 196:593-594, 1966
15. Mullen KD, Martin JV, Mendelson WB, et al: Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy. Metab Brain Dis 4:253-260, 1989
16. Mullen KD, Martin JV, Mendelson WB, et al: Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy. Lancet 4:457-459, 1988
17. Mullen KD, Szauter KM, Kaminsky-Russ K: The benzodiazepine hypothesis of hepatic encephalopathy: Historical development and current status of human studies, in Bengtsson F, Jeppsson B, Almdal T, et al (eds): Progress in Hepatic Encephalopathy and Metabolic Nitrogen Exchange. Boca Raton, FL, CRC, 1991, pp 107-114
18. Yurdaydin C, Gu Zi-Qiang, Nowak G, et al: Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: Relationship between brain concentration and severity of encephalopathy. J Pharmacol Exp Ther 265:565-571, 1993
19. Gammal SH, Basile AS, Geller D, et al: Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Hepatology 11:371-377, 1989
20. A receptor-complex in an experimental model of hepatic encephalopathy: Evidence for elevated levels of an endogenous benzodiazepine receptor ligand. J Neurochem 53:1057-1063, 1989
21. Rossle M, Deckert J, Jones EA: Autoradiographic analysis of GABA-benzodiazepine receptors in an animal model of acute hepatic encephalopathy. Hepatology 10:143-147, 1989
22. Marangos PJ, Patel J: The benzodiazepine receptor, in Marangos PJ, Campbell IC, Cohen RM (eds): Brain receptor methodologies: Part B. Amino Acids, Pepetides, Psychoactive Drugs. London, Academic Press, 1984, pp 177-188
23. Rothstein JD, Mckhann G, Guarneri P, et al: Increased endogenous neuropeptide ligand for benzodiazepine receptors in hepatic encephalopathy. Hepatology 11:708-709, 1990
24. Rothstein JD, Guidotti A, Tinuper P, et al: Endogenous benzodiazepine receptor ligands in idiopathic recurring stupor. Lancet 340:1002-1004, 1992
25. Mullen KD, Martin JV, Mendelson WB, et al: Further evidence that hepatic encephalopathy in the galactosamine rabbit model may be mediated by an endogenous benzodiazepine compound, in Soeters PB, Wilson JHP, Meijer AJ, et al (eds): Advances in Ammonia Metabolism and Hepatic Encephalopathy. New York, Elsevier, 1988, pp 333-337
26. Bosman DK, VanDen Buijs CACG, De Haan JG, et al: The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat. Gastroenterology 101:772-781, 1991
27. Baraldi M, Zeneroli ML, Ventura E, et al: Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: Reversal by a benzodiazepine antagonist. Clin Sci 67:167-175, 1984
28. Spivey WH: Flumazenil and seizures: Analysis of 43 cases. J Clin Ther 14:292-305, 1992